6HY-29117-68344
3 vaccinations
5 coded responses
18 check-ins
5 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 300 / GA
- Registered
- 2022-07-05
- Relationship
- Child or adolescent in my care
- Guardian
- V7E-78124-19162
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-03
Dose 1 — Pfizer-BioNTech
-
2022-07-05
Registered in v-safe
-
2022-07-05
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-07-06
- 2022-07-07
- 2022-07-08
-
2022-07-09
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Conjunctivitis — Feeling: GoodFree text: ConjunctivitisMedDRA releases: 2024-11 · check-in free text available
- 2022-07-12
-
2022-07-17
Survey response — day 14, dose 1, dependentMedDRA: Pyrexia, Respiratory tract congestion — Feeling: FairFree text: Congestion and slight feverMedDRA releases: 2024-11 · check-in free text available
-
2022-07-24
Survey response — day 21, dose 1, dependentMedDRA: Diarrhoea, Pyrexia, Vomiting — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diarrhea, fever, and vomitingMedDRA releases: 2024-11 · check-in free text available
-
2022-07-24
Report sent to call center — day 21, dose 1, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-25
-
2022-08-02
Dose 2 — Pfizer-BioNTech
- 2022-08-07
- 2022-08-08
- 2022-08-09
- 2022-08-16
-
2022-08-25
Survey response — day 21, dose 2, dependentMedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Survey response — day 28, dose 2, dependentMedDRA: Cough — Feeling: GoodFree text: Cough (intermittent)MedDRA releases: 2024-11 · check-in free text available
- 2022-09-06
- 2022-09-13
-
2022-09-27
Dose 3 — Pfizer-BioNTech
- 2022-11-01
- 2023-01-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-03 | Pfizer-BioNTech | No |
| 2 | 2022-08-02 | Pfizer-BioNTech | No |
| 3 | 2022-09-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-24 | Unsuccessful |
Free text
Release 12 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Conjunctivitis
Release 12 — day 14, dose 1, dependent
Symptoms: Congestion and slight fever
Release 12 — day 21, dose 1, dependent
Symptoms: Diarrhea, fever, and vomiting
Release 12 — day 21, dose 2, dependent
Symptoms: Cough
Release 12 — day 28, dose 2, dependent
Symptoms: Cough (intermittent)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Conjunctivitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release